Danaher Corp (DHR):企業の財務・戦略的SWOT分析

◆英語タイトル:Danaher Corp (DHR) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14213
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Danaher Corp (DHR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Danaher Corp (Danaher) is a medical technology company which designs, manufactures and markets medical, professional, commercial and industrial products and services. It offers a wide range of testing instruments, communications solutions, water quality systems, medical diagnostics solutions, life science research tools, professional microscopes, dental products, product identification solutions, automation solutions and sensors and controls solutions. The company operates manufacturing, sales, distribution, service and administrative facilities in Europe, Australia, Asia and the Americas. The company distributes its products to its customers across the Americas; Europe, Middle East, Africa and Asia-Pacific through direct sales personnel and independent distributors. Danaher is headquartered in Washington DC, the US.

Danaher Corp Key Recent Developments

Feb 26,2019: GE to divest biopharma business to Danaher for $21.4bn
Feb 26,2019: GE inks $21 billion biopharma sale to Danaher in U-turn under Culp
Jan 29,2019: Danaher reports fourth quarter and full year 2018 results
Jan 07,2019: Danaher Expects Q4 Adj. EPS To Be At Or Near High-end Of Prior Outlook
Dec 13,2018: Danaher Projects 2019 Non-GAAP Core Revenue Growth Of Approx. 4% – Quick Facts

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Danaher Corp – Key Facts
Danaher Corp – Key Employees
Danaher Corp – Key Employee Biographies
Danaher Corp – Major Products and Services
Danaher Corp – History
Danaher Corp – Company Statement
Danaher Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Business Unit
Section 2 – Company Analysis
Company Overview
Danaher Corp – Business Description
Product Category: Analytical and Physical Instrumentation
Performance
Product Category: Dental Products
Performance
Product Category: Product Identification
Performance
Product Category: Research and Medical Products
Performance
Product Category: Dental
Capital Expenditure
Overview
Performance
Key Stats
Product Category: Diagnostics
Capital Expenditure
Overview
Performance
Key Stats
Product Category: Environmental & Applied Solutions
Capital Expenditure
Overview
Performance
Key Stats
Product Category: Life Sciences
Capital Expenditure
Overview
Performance
Key Stats
Geographical Segment: All Other
Performance
Overview
Geographical Segment: China
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Japan
Performance
Geographical Segment: The US
Performance
R&D Overview
Danaher Corp – Corporate Strategy
Danaher Corp – SWOT Analysis
SWOT Analysis – Overview
Danaher Corp – Strengths
Danaher Corp – Weaknesses
Danaher Corp – Opportunities
Danaher Corp – Threats
Danaher Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Oil & Gas Financial Deals and Alliances
Danaher Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Danaher Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Danaher Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 26, 2019: GE to divest biopharma business to Danaher for $21.4bn
Jan 29, 2019: Danaher reports fourth quarter and full year 2018 results
Dec 13, 2018: Danaher Initiates 2019 Outlook
Oct 18, 2018: Danaher announces third quarter 2018 results
Jul 19, 2018: Danaher announces plan to Spin off dental business into an independent, publicly traded company
Apr 25, 2018: Diebold Nixdorf Elects Board Members At Annual Shareholders Meeting
Apr 19, 2018: Danaher Announces First Quarter 2018 Results
Mar 07, 2018: Danaher Provides Update on First Quarter 2018 Financial Performance
Jan 30, 2018: Danaher Reports Fourth Quarter And Full Year 2017 Results
Jan 20, 2018: Danaher Announces Transition Plan for Chief Financial Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Danaher Corp, Key Facts
Danaher Corp, Key Employees
Danaher Corp, Key Employee Biographies
Danaher Corp, Major Products and Services
Danaher Corp, History
Danaher Corp, Other Locations
Danaher Corp, Subsidiaries
Danaher Corp, Business Unit
Danaher Corp, Key Competitors
Danaher Corp, Ratios based on current share price
Danaher Corp, Annual Ratios
Danaher Corp, Annual Ratios (Cont...1)
Danaher Corp, Annual Ratios (Cont...2)
Danaher Corp, Interim Ratios
Danaher Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Danaher Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Danaher Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Danaher Corp, Performance Chart (2014 - 2018)
Danaher Corp, Ratio Charts
Danaher Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Danaher Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Danaher Corp (DHR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GFT Technologies AG (GFT):企業の財務・戦略的SWOT分析
    Summary GFT Technologies AG (GFT Technologies) is a technology company that implements, develops, and maintains information technology solutions. The company’s services comprise application management, bespoke development, product based implementation, and business and IT consultation services. It a …
  • Victrex plc (VCT):企業の財務・戦略的SWOT分析
    Summary Victrex Plc (Victrex) is a chemical company that manufactures and markets high-performance polymer materials and solutions. The company operates through its business units such as Victrex polymer solutions and Invibio biomaterial solutions. Its Victrex polymer solutions unit serves industria …
  • Tokmanni Group Oyj (TOKMAN):企業の財務・戦略的SWOT分析
    Tokmanni Group Oyj (TOKMAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Emerson Radio Corporation (MSN):企業の財務・戦略的SWOT分析
    Emerson Radio Corporation (MSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Starwood Property Trust Inc:企業のM&A・事業提携・投資動向
    Starwood Property Trust Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Starwood Property Trust Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Bega Cheese Ltd:企業のM&A・事業提携・投資動向
    Bega Cheese Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bega Cheese Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • CVR Energy, Inc.:企業の戦略・SWOT・財務分析
    CVR Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary CVR Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sibanye Gold Ltd:企業の戦略・SWOT・財務情報
    Sibanye Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Sibanye Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Scheid Vineyards Inc:企業の戦略・SWOT・財務情報
    Scheid Vineyards Inc - Strategy, SWOT and Corporate Finance Report Summary Scheid Vineyards Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SPR Therapeutics LLC:医療機器:M&Aディール及び事業提携情報
    Summary SPR Therapeutics LLC (SPR Therapeutics) is a medical device company that develops and commercializes neurostimulation products. The company develops therapies for post-surgical pain, neuropathic pain, and musculoskeletal pain. It offers percutaneous peripheral nerve stimulation system for in …
  • Insurance Australia Group Limited:企業の戦略・SWOT・財務情報
    Insurance Australia Group Limited - Strategy, SWOT and Corporate Finance Report Summary Insurance Australia Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive info …
  • Fate Therapeutics Inc (FATE):企業の財務・戦略的SWOT分析
    Fate Therapeutics Inc (FATE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Bellicum Pharmaceuticals Inc (BLCM):企業の財務・戦略的SWOT分析
    Summary Bellicum Pharmaceuticals, Inc. (Bellicum) is a clinical stage biopharmaceutical company, which is engaged in developing cellular immunotherapies for the treatment of cancer. The company develops its product candidates through its chemical induction of dimerization technology platforms in the …
  • Covanta Holding Corp (CVA):電力:M&Aディール及び事業提携情報
    Summary Covanta Holding Corp (Covanta) is a provider of sustainable waste and energy solutions. It generates electricity from its Energy-from-Waste (EfW); and recycles ferrous and non-ferrous metals through its subsidiaries. Its Energy-from-Waste (EfW) facilities convert more than 20 million tons of …
  • Calpine Corp:企業の戦略的SWOT分析
    Calpine Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Merus Labs International Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Merus Labs International Inc (Merus Labs International), formerly Merus Labs Inc, a subsidiary of Norgine BV, is a pharmaceutical company that provides medicinal products. The company offers products in the therapeutic areas of cardiovascular, oncology support, women's health, urology, and i …
  • Kimco Realty Corp (KIM):企業の財務・戦略的SWOT分析
    Kimco Realty Corp (KIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Waterloo Industries Inc:企業の戦略的SWOT分析
    Waterloo Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Redx Pharma Plc (REDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Redx Pharma Plc (Redx Pharma), formerly Redx Pharma Ltd is a drug discovery and development company that develops early stage and small molecule therapeutics. The company’s pipeline products include inhibitors for oncology and anti-infectives for treatment of diseases that include influenza …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆